[Decreasing of suxamethonium induced apnea with Akrinor].
D000759:Adjuvants, Anesthesia / Q000009:adverse effects*; D001049:Apnea / Q000139:chemically induced* / Q000188:drug therapy; D000697:Central Nervous System Stimulants / Q000627:therapeutic use*; D006801:Humans; D013390:Succinylcholine / Q000009:adverse effects*; D013997:Time Factors
D000759:Adjuvants, Anesthesia; D000697:Central Nervous System Stimulants; D013390:Succinylcholine
Verkürzung der Suxamethoniumpanoe durch Akrinor.